Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations

Breadcrumb

  1. Emmes Group

Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS

Go back to Resources

Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics

Go back to Resources

Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics

Authors:

Location:

Go back to Resources

Pediatric transplantation of the kidney, liver and heart: Summary report

Go back to Resources

Pediatric transplantation of the kidney, liver and heart: Summary report

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Ocular risk factors for developing Neovascular AMD in the fellow eyes of patients with unilateral Neovascular AMD

Go back to Resources

Ocular risk factors for developing Neovascular AMD in the fellow eyes of patients with unilateral Neovascular AMD

Authors:

Location:

Go back to Resources

NIH-supported national transplant registry

Go back to Resources

NIH-supported national transplant registry

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

NIH-Supported National Islet Transplantation Registry

Go back to Resources

NIH-Supported National Islet Transplantation Registry

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Late Breaking Results of the First International Multicenter Trial of Islet Transplantation in Type 1 Diabetes with the Edmonton Protocol

Go back to Resources

Late Breaking Results of the First International Multicenter Trial of Islet Transplantation in Type 1 Diabetes with the Edmonton Protocol

Authors:

Location:

Go back to Resources

Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease

Go back to Resources

Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease

Authors:

Location:

Go back to Resources

Initial Results of the Protein Kinase C b Inhibitor Diabetic Macular Edema Study (PKC-DMES)

Go back to Resources

Initial Results of the Protein Kinase C b Inhibitor Diabetic Macular Edema Study (PKC-DMES)

Authors:

Location:

Go back to Resources

Impact of Antioxidants, Zinc, and Copper on Cognition in the Elderly: A Randomized, Controlled Trial

Go back to Resources

Impact of Antioxidants, Zinc, and Copper on Cognition in the Elderly: A Randomized, Controlled Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 144
  • Page 145
  • Page 146
  • Page 147
  • Current page 148
  • Page 149
  • Page 150
  • Page 151
  • Page 152
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Contact Us
    • Locations
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • Terms of Use
  • ISO Certification